Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Citi
Colorcon
Johnson and Johnson
Accenture
Deloitte
Harvard Business School
Merck
AstraZeneca

Generated: June 20, 2018

DrugPatentWatch Database Preview

BRISTAMYCIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Bristamycin, and what generic alternatives are available?

Bristamycin is a drug marketed by Bristol and is included in two NDAs.

The generic ingredient in BRISTAMYCIN is erythromycin stearate. There are one hundred and two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for BRISTAMYCIN
US Patents:0
Applicants:1
NDAs:2
Formulation / Manufacturing:see details
DailyMed Link:BRISTAMYCIN at DailyMed
Drug patent expirations by year for BRISTAMYCIN

US Patents and Regulatory Information for BRISTAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol BRISTAMYCIN erythromycin stearate TABLET;ORAL 061304-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol BRISTAMYCIN erythromycin stearate TABLET;ORAL 061887-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Baxter
Chubb
Harvard Business School
Johnson and Johnson
Colorcon
US Department of Justice
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.